|
|
||||||||
Department of Physiology, Biochemistry and Biometrics, Faculty of Veterinary Medicine, Ghent University, B-9820 Merelbeke, Belgium
Corresponding author: C. Burvenich; e-mail: christian.burvenich{at}ugent.be.
| ABSTRACT |
|---|
|
|
|---|
Key Words: steroid diapedesis viability polymorphonuclear leukocyte
Abbreviation key: BME = bovine mammary epithelial, HBSS = Hanks balanced salt solution, PI = propidium iodide, PMN = polymorphonuclear leukocytes, ZAS = zymosan-activated serum.
| INTRODUCTION |
|---|
|
|
|---|
The incidence of infection depends on the stage of lactation and is usually highest after calving and at drying off (Burvenich et al., 1999). In addition, PMN function varies with stage of lactation, concomitant with variations in steroid hormone concentrations (Osterlundh et al., 2002). During the periparturient period, cows are subjected to major changes in sex steroid hormone levels that may induce suppression of immune function. In the last week before parturition, plasma concentrations of 17ß-estradiol may rise steeply, peaking in the last 3 d before delivery but then falling rapidly to regain basal values directly after calving. During the last month of gestation, the high plasma concentration of progesterone declines, but a dramatic fall usually occurs only in the last 2 d before delivery. It is not yet fully understood how these changes in sex steroid concentrations relate to changes in immune response.
Once their function in the inflammatory foci is performed, PMN need to die by apoptosis. The local regulation of PMN apoptosis within the mammary gland is not yet fully understood, although it may contribute to the reported decreased viability of milk PMN compared with blood PMN (Mehrzad et al., 2001). Moreover, low viability of resident milk PMN is observed during early lactation (Burvenich et al., 2003), suggesting a potential influence of changed physiological factors such as 17ß-estradiol and progesterone on the viability of migrated PMN.
It is also evident that many of the PMN functions likely to be induced during inflammation, are affected by glucocorticosteroids (Cox, 1995). Dexamethasone causes inhibition of apoptosis in human PMN (Cox, 1995; Kato et al., 1995; Liles et al., 1995; Meagher et al., 1996; Cox and Austin, 1997; Nittoh et al., 1998) as well as an increased chemotactic ability of bovine PMN (Anderson et al., 1999). Both effects may stimulate resolution of inflammation, if the delay in PMN apoptosis is not followed by PMN necrosis. It should also be noted that contradictory results on the effect of dexamethasone have been reported.
The aim of the current study was to investigate, using an in vitro model with different types of cell layers (bovine mammary epithelial cells and fibroblasts), whether different steroid hormone treatments (17ß-estradiol, progesterone, and dexamethasone) have an influence on the PMN diapedesis capacity and viability. In addition, PMN viability was further differentiated into apoptosis vs. necrosis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-lactalbumin and
s1-casein. Culture medium contained 40% Hams F12, 30% RPMI 1640, 20% NCTC 135, 10% fetal calf serum (all from Gibco BRL, Life Technologies Inc., Gaithersburg, MD), 2% antibiotic-antimycotic solution, 0.1% lactose, 0.1% lactalbumin hydrolysate, 1.2 mM glutathione, 10 µg/mL L-ascorbic acid, 1 µg/mL hydrocortisone, and 1 µg/mL insulin (all from Sigma Chemical Co., St. Louis, MO). Stock cell cultures (3 x 106 cells) were grown in 75-cm2 tissue culture treated, vented flasks containing 20 mL of the culture medium. Half of the medium was refreshed every 2 d. Cells were subcultured once every 3 to 5 d when flasks were 70 to 80% confluent. Passage of cells in the flasks was performed by aspirating the medium, rinsing with 10 mL of PBS (Sigma Chemical Co.), and then incubating the cells with 10 mL of a 0.05% trypsin-EDTA solution for 5 min at 37°C in 5% CO2. Once the cells detached, they were suspended in 15 mL of fetal calf serum, and centrifuged (221 x g for 5 min). The supernatant was removed and the cells were counted with a Coulter counter (Coulter counter ZF, Coulter Electronics Ltd., Luton, UK).
Culture of Fibroblasts
Fibroblasts (bovine dermal fibroblasts) were purchased from Istituto Zooprofilattico Sperimentale Della Lombardia e Dell Emilia-Romagna. Stock cell cultures (3 to 4 x 106 cells) were grown and trypsinized as described for BME-UV1.
Coating of Synthetic Membrane Inserts with Collagen
Membrane inserts (12 mm diameter, 3 µm pore size, Millicell-PCF, Millipore Corp., Bedford, MA) were coated with a commercial 0.1% calfskin collagen (type I) solution (Sigma Chemical Co.) by adding 100 µL of this solution to both sides of the inserts. The inserts were dried overnight at room temperature under a laminar airflow hood.
In Vitro Model with Bovine Mammary Epithelial Cells
Inverted collagen-coated inserts were placed in 6-well tissue culture plates with both surfaces bathed in 8 mL of culture medium and seeded with 75 µL of an epithelial cell suspension containing 3 x 105 cells/mL. Inserts were kept in a 5% CO2 incubator at 37°C; half of the medium was changed every 2 d. On d 15, inserts were used for the experiment. In parallel, some inserts were used for scanning electron microscopy and microtomy as an extra morphological control of the confluence of the BME-UV1 layers.
In Vitro Model with Bovine Mammary Epithelial Cells and Fibroblasts
Fibroblasts (1.5 x 105 cells/mL) were plated on the inverted collagen-coated inserts and incubated at 37°C in 5% CO2 for 12 h. After 12 h, inserts were irradiated with UV light for 5 min to inhibit fibroblast overgrowth in the model. One hundred microliters of 0.1% calfskin collagen solution was layered onto the irradiated fibroblasts and the model was incubated at 37°C in 5% CO2. After 3 h, BME-UV1 cells were added and incubated at 37°C in 5% CO2 for 15 d. Half of the culture medium was changed every 2 d. In parallel, some inserts were used for scanning electron microscopy and microtomy as an extra control of the confluence of the BME-UV1 layers.
Determination of Transepithelial Resistance
Confluence of the monolayers was determined by transepithelial electrical resistance. Transepithelial electrical resistance was measured using an Ohmmeter (World Precision Instruments, New Haven, CT). Collagen-coated inserts with fibroblasts served as a control. Inserts with a transepithelial electrical resistance higher than 800
x cm2 were used in the experiment, because a resistance of 800
x cm2 and higher has been shown to give good resistance against trypan blue diffusion during more than 120 min (data not shown).
Isolation of PMN
Fifteen clinically healthy Holstein cows in their last 4 wk of gestation were selected. Seven cows were used for the study of the influence of 17ß-estradiol, progesterone, and dexamethasone on the diapedesis of PMN through different cell layers. To study the influence of 17ß-estradiol and progesterone on the migration through collagen-coated inserts, 8 extra cows were used. The cows were used after approval by the Ethical Committee of the Faculty of Veterinary Medicine, University Ghent, Belgium. Blood for PMN isolation was collected via venipuncture of the jugular vein using 60-mL sterile tubes containing 30 mL of Alsever solution as anticoagulant (0.42% NaCl, 0.8% trisodium citrate, 2.05% glucose in PBS adjusted to pH 6.1 by addition of a 10% solution of citric acid). Polymorphonuclear leukocytes were isolated using the method described by Roets et al. (1999) using NH4Cl for lysis of erythrocytes after removal of the buffy coat. The cell pellets comprising isolated PMN were then resuspended and the cell concentration of the suspension was determined using a Coulter counter. The concentration of cells was then adjusted to 8.3 x 106 cells/mL with Hanks balanced salt solution (HBSS) containing 0.1% BSA.
Analysis of 17ß-Estradiol and Progesterone Plasma Levels
Plasma was removed after the first centrifugation step of the PMN isolation procedure and was stored at 20°C. Plasma levels of 17ß-estradiol and progesterone were determined using a radioimmunoassay technique according to Henry et al. (1987). Briefly, the plasma concentration of 17ß-estradiol was measured after extraction with diethylether without further purification, using an antiserum against estradiol-3-hemisuccinate-BSA raised in sheep. The plasma concentration of progesterone was measured after extraction with petroleum ether without further purification, using an antiserum against progesterone-11-hemisuccinate-BSA raised in sheep. The detection limit in bovine plasma for 17ß-estradiol and progesterone was 20 pg/mL and 0.5 ng/mL, respectively. The intra- and interassay coefficients of variation were 5.75 and 8.30% for 17 ß-estradiol, and 7.05 and 8.75% for progesterone, respectively. Estrone was not determined in plasma.
Incubation of PMN with 17ß-Estradiol, Progesterone, and Dexamethasone
Polymorphonuclear leukocytes were incubated with 1 ng/mL 17ß-estradiol (1,3,5(10)-Estratriene-3,17-ß-diol), 50 ng/mL progesterone (4-Pregnene-3,20-dione), or 4 ng/mL dexamethasone (Sigma Chemical Co.) for 3 h at 37°C. Stock solutions of 17ß-estradiol, progesterone, and dexamethasone were prepared in 100% ethanol and diluted so that a final concentration of 0.1% ethanol was present in every steroid preparation, to obtain a constant solvent concentration. A control sample was run in parallel in which steroid hormones were replaced by medium (HBSS with 0.1% ethanol and 0.1% BSA).
Preparation of Zymosan-Activated Serum
A bovine serum pool was activated by incubating the serum with 15 mg/mL of zymosan (from Saccharomyces cerevisiae, Sigma Chemical Co.) at 37°C for 60 min. After 1 h at 37°C, the mixture was incubated at 56°C for 30 min to destroy complement components, with the exception of C5a. Component C5a is stable under these conditions (Rainard, 2003). Using heat inactivation, a stable C5a concentration is obtained in the serum, and formation of additional C5a during the diapedesis assay can be avoided. Zymosan particles were removed by centrifuging the mixture for 15 min at 2300 rpm (4°C). The obtained supernatant was filtered through a 0.2-µm filter (Millipore) and stored at 80°C until use. For the PMN diapedesis assay, the zymosan-activated serum (ZAS) stock solution was diluted 1:5 with HBSS supplemented with 0.1% BSA. The concentration of C5a in the diluted ZAS solution was 456 ng/mL. The concentration was determined using ELISA as described by Rainard et al. (1998).
PMN Diapedesis Assay
After 15 d of culture, inserts containing a confluent layer of epithelial cells were washed twice with HBSS containing 0.1% BSA. The inserts were placed upright in 24-well plates. Polymorphonuclear leukocytes (2.5 x 106, 300 µL of an 8.3 x 106 cells/mL suspension) were added on top of the inserts and stimulated to migrate across the membrane by the addition of 400 µL of diluted ZAS to the lower well. The 24-well plates were then placed into a 37°C incubator with 5% CO2. After 2 h, inserts were removed and the migrated PMN were counted in the lower well of the 24-well plates.
Flow Cytometric Analysis of PMN Viability Differentiated into Apoptosis and Necrosis
Apoptosis and necrosis of bovine PMN was quantified using a dual-color flow cytometric procedure with staining of exposed phosphatidylserine with FITC-Annexin-V (Roche Diagnostics, Basel, Switzerland) and of cellular DNA with propidium iodide (PI) as described by Van Oostveldt et al. (1999). Briefly, labeling solution was prepared by adding 20 µL of FITC-Annexin-V reagent and 10 µL of PI solution (50 µg/mL) to 1000 µL of incubation buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl2). Polymorphonuclear leukocytes (1 x 105) were centrifuged (200 x g, 10 min) and resuspended in 100 µL of labeling solution. The mixture was incubated for 10 min in the dark at room temperature and the cells were immediately analyzed by flow cytometry. Fluorescence was measured with a FACS-can flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA). Dot plots were gated for PMN based on cell size by forward scattering and on granularity by side scattering. The gating of the PMN population was refined by defining the PMN population with the CH138 monoclonal antibody (VMRD Inc., Pullman, WA), an IgM isotype antibody that specifically recognizes bovine PMN. For this purpose, an extra aliquot of the isolated cell suspension of one cow (1 x 106/mL) was incubated during 30 min with 100 µL of the CH138 antibody diluted 1:66 in RPMI 1640 with 1% BSA. After incubation, cells were centrifuged and washed. Cells were labeled with 100 µL of a FITC-labeled secondary antibody (STAR9B, Serotec, Oxford, UK.) diluted 1:250 in RPMI 1640 with 1% BSA during 30 min in the dark on ice. After incubation, cells were centrifuged and washed. The PMN pellet was fixed by adding 500 µL of a 1% paraformaldehyde solution in PBS and stored in the dark at 4°C until measurement by flow cytometry.
Once the gate for the PMN population was defined, apoptosis and necrosis was determined by plotting log FL2 (PI) vs. log FL1 (Annexin-V-FITC). Percentage of PMN that were positive for Annexin-V-FITC and negative for PI because of their membrane integrity were considered apoptotic. Percentage of PMN that were positive for PI and Annexin-V-FITC were considered necrotic. Data were corrected for autofluorescence, which was defined as the fluorescence associated with nonlabeled freshly isolated PMN.
Statistical Analyses
The effect of endogenous 17ß-estradiol and progesterone levels on diapedesis capacity (i.e., number of migrated PMN) and viability (%) (i.e., 100 % necrotic PMN % apoptotic PMN) before and after diapedesis was studied by simple linear regression. The 3 treatments (17ß-estradiol, progesterone, and dexamethasone) and the control samples were compared for PMN viability before diapedesis by the mixed model with cow as random effect and treatment as fixed effect. Pairwise comparisons between the treatments were adjusted by Tukeys multiple comparisons procedure. The effect of the treatment and type of cell layer on viability, diapedesis capacity, the number of viable PMN (i.e., number of migrated PMN x % viability) and the ratio of viable PMN after and before migration was assessed by the mixed model with cow as random effect and the treatment, type of cell layer, and their interaction as fixed effects. The effect of treatment and cell layer type on apoptosis and necrosis of PMN was assessed as described for viability.
| RESULTS |
|---|
|
|
|---|
No significant influence of endogenous 17ß-estradiol (P = 0.38) or progesterone levels (P = 0.56) on the diapedesis capacity of bovine blood PMN was found (n = 13). Furthermore, endogenous 17ß-estradiol or progesterone levels did not significantly influence viability before (P = 0.90 and P = 0.63, respectively) or after diapedesis (P = 0.43 and P = 0.79, respectively) (n = 7).
Influence of Treatment and Cell Layer Type
Influence on viability before migration.
Before migration, the mean value for viability (91%) was slightly higher for dexamethasone (n = 7) than for control (88%), 17ß-estradiol (86%), and progesterone (83%) (n = 11, n = 9, and n = 7, respectively). A significant pairwise difference in viability was only found between dexamethasone and progesterone treatment (P = 0.0043).
Influence on Diapedesis Capacity and Viability After Migration
Following migration, the treatment (P = 0.0014) and cell layer type (P <0.0001) had an effect on the number of viable PMN in the lower compartment of the model; a significant interaction between treatment and cell layer type was found (P = 0.0136). The number of viable PMN in the lower compartment is determined by the number of migrated PMN and the percentage viability of these cells after migration. Both the treatment (P = 0.003) and cell layer type (P <0.0001) had a significant effect on the number of migrated PMN, with a significant interaction (P = 0.013) occurring between treatment and cell layer type. The percentage viability after migration was influenced by treatment (P = 0.006) and cell layer type (P = 0.0001) with again a significant interaction (P = 0.028).
Influence of 17ß-estradiol treatment.
A significantly lower number of viable PMN in the lower compartment was found after 17ß-estradiol treatment as compared with the control (P = 0.008) and the dexamethasone treatment (P = 0.0004). The influence of 17ß-estradiol treatment was only significant after migration through collagen (P = 0.0294 and P = 0.0146 for 17ß-estradiol compared with control and dexamethasone, respectively) and not for migration through epithelial cells with or without fibroblasts (Figure 1A
). Regarding the influence of 17ß-estradiol on the number of migrated PMN and percentage viability after migration, significant differences were found between 17ß-estradiol compared with the control (diapedesis: P = 0.058; viability: P = 0.0099) and the dexamethasone treatment (diapedesis: P = 0.004; viability: P = 0.0033) (Figure 1B, 1C
).
|
Influence of dexamethasone treatment.
No significant effects on the number of viable PMN were found between dexamethasone treatment and control regardless of cell layer type. However, when comparing the dexamethasone treatment with 17ß-estradiol, a significant increase in number of viable PMN was found after migration through collagen (P = 0.0052) (Figure 1A
).
Influence of cell layer type.
After migration through collagen, a significantly higher number of viable PMN was found compared with migration through epithelial cells (P <0.0001), but no extra significant effect was found by adding fibroblasts to the epithelial cell layer (P = 0.73). After 17ß-estradiol or progesterone treatment, the decrease in the number of viable PMN after migration through epithelial cells was no longer significant (Figure 1A
).
For diapedesis capacity and viability after migration, the same pairwise significant differences were found between collagen and the 2 other cell layer types (diapedesis: P <0.01, viability: P <0.01). Moreover, viability was significantly influenced by adding fibroblasts (P = 0.0503) (Figure 1B, 1C
).
Influence on apoptosis and necrosis.
When discriminating the nonviable PMN population in apoptotic vs. necrotic cell populations, only apoptosis (P <0.0001) of bovine blood PMN was influenced by the cell layer and not necrosis (P = 0.165) (n = 7). Adding fibroblasts to epithelial cells caused an extra, significant effect on apoptosis (P = 0.038) (Figure 2
). No significant effect of the treatment on apoptosis or necrosis was found (Table 1
).
|
|
| DISCUSSION |
|---|
|
|
|---|
A remarkable aspect from the current study, as well as from previous studies in cows (Smits et al., 1996) and sows (Osterlundh et al., 2002), was the high variability in PMN chemotactic ability observed between the individual animals. It was therefore tested whether this interanimal variability, which can be responsible for intercow differences in resistance against mastitis (for review see Burvenich et al., 2003), is correlated with the endogenous 17ß-estradiol and progesterone levels before PMN isolation. Because no correlation was found between the endogenous 17ß-estradiol and progesterone levels and diapedesis capacity, it can be concluded that slight changes in these hormone levels during late gestation are not responsible for the observed intercow differences. Neither was the high intercow variability observed in our study caused by differences in viability just before migration, because the same results were found for number of viable PMN and ratio of viable PMN after and before migration. Our finding concerning the influence of endogenous 17ß-estradiol and progesterone levels on diapedesis is supported by the study from Subandrio et al. (2000), although contradictory results are reported in the literature. Comparison between different studies is complicated by the use of different migration techniques, e.g., random vs. directed migration. Subandrio et al. (2000) evaluated the chemotactic ability of blood PMN isolated from cows in estrus, diestrus, and after ovariectomy and could not observe a significant difference between the different reproductive stages. However, Roth et al. (1983) found an enhanced random migration with increased serum 17ß-estradiol and progesterone concentrations suggesting an influence of sex steroid hormones on PMN function during the normal estrous cycle.
Before migration, no significant influence of 17ß-estradiol, progesterone, or dexamethasone treatment on PMN viability was found compared with the control. The scarce reports concerning the influence of 17ß-estradiol and progesterone on viability of blood PMN are restricted to apoptosis of human PMN and reveal conflicting results. Cox (1995) and Liles et al. (1995) have reported that progesterone has no influence on the apoptosis of blood PMN, whereas Molloy et al. (2003) describe that physiological doses of 17ß-estradiol and progesterone cause a delay in spontaneous apoptosis, associated with a noticeable increase in PMN survival and a more adequate immune response during pregnancy in humans. More information is available on dexamethasone treatment of PMN, although it is also restricted to humans. Inhibition of PMN apoptosis was found for dexamethasone treatment by Cox (1995), Cox and Austin (1997), Liles et al. (1995), and Meagher et al. (1996). The high viability of PMN in the control samples after 3 h of incubation in our study made it more difficult to measure a significant inhibition of apoptosis by dexamethasone. However, when compared with progesterone treatment, where viability was lowest after 3 h of incubation, the positive effect of dexamethasone on PMN viability was indeed significant. A positive influence of dexamethasone on the PMN viability is therefore not excluded. It can be suggested that the viability of control samples would have decreased after a longer incubation period, so that the difference with the dexamethasone treatment would have been more clearly expressed. Nevertheless, a 3-h incubation period was chosen to guarantee a high viability just before migration.
The influence of steroid hormone treatment and cell layer type on diapedesis and viability after migration was evaluated by the number of viable PMN in the lower compartment of the in vitro model (number of migrated PMN x % viability after migration). 17ß-estradiol significantly reduced the number of viable PMN after migration through collagen, although this suppressive effect was no longer significant when other cell layers were added. Because a less efficient migration through epithelial cells is evident from our data and the literature (Smits et al., 2000), the significance of 17ß-estradiol treatment may be masked by adding epithelial cells to the model. Alternatively, it has been suggested that migration through collagen is mediated by mechanisms other than migration through epithelial cells (Parkos, 1997). The negative influence of 17ß-estradiol on the number of viable PMN is caused by an influence on the diapedesis capacity as well as by an effect on the viability after migration. As described above, this was not due to a lower viability before migration nor was it caused by differences in endogenous 17ß-estradiol or progesterone levels. A potential role in the mechanism of immune depression around parturition can be suggested for 17ß-estradiol, whose levels typically peak at parturition. Previous studies support the hypothesis that sex steroids reduce PMN chemotaxis of bovine (Subandrio et al., 2000), equine (Watson et al., 1987), or human (Miyagi et al., 1992) PMN following in vivo administration of 17ß-estradiol or after in vitro treatment with 17ß-estradiol. However, these reports are restricted to the influence on chemotaxis; the influence on migration through epithelial cells and fibroblasts has not been considered previously in vitro. By adding epithelial cells and fibroblasts, interaction of these cells with PMN is also considered, although the role of endothelial cells is not taken into account. It should be noted that comparison of our results with the literature data is not completely straightforward because of species differences, the differences in endogenous or exogenous steroid hormone concentrations, or both, and the different types of migration (diapedesis vs. chemotaxis and random migration) studied. Nevertheless, a general conclusion from our study and from the literature is the suppressive effect of 17ß-estradiol on PMN migration. This effect can be mediated by interaction of 17ß-estradiol with its receptor. However, the presence of estrogen receptors on bovine PMN has not yet been demonstrated. An alternative hypothesis is that the effect of 17ß-estradiol is not receptor mediated. Because other cells (<10%) are present in the PMN isolates, we cannot exclude the possibility that 17ß-estradiol exerts its influence on PMN in a paracrine way.
In the current study, progesterone had no significant influence on the number of viable PMN compared with the control. Conflicting findings are reported for progesterone in literature. In the study of Subandrio et al. (2000), a significant reduction in PMN chemotaxis is reported following progesterone treatment of ovariectomized cows. Random migration of blood PMN is reduced by progesterone administration to ovariectomized mares as well as by in vitro progesterone treatment of PMN from acyclic ponies (Watson et al., 1987). However, Miyagi et al. (1992) reported that progesterone slightly enhances the chemotactic ability of human PMN.
Although no significant influence was observed for dexamethasone treatment compared with the control, a significant stimulating effect was noted, compared with 17ß-estradiol. This finding may support a role for dexamethasone in the recovery from a depressed number of viable PMN at the site of infection by 17ß-estradiol. Again, contradictory results are reported in the literature. Dexamethasone administration to cattle results in an increase of PMN chemotaxis (Anderson et al., 1999), whereas in vitro dexamethasone treatment of human PMN causes a significant fall in chemotaxis (Lomas et al., 1991).
The subsequent removal of PMN from the site of infection by apoptosis after performance of their function is as important as efficient migration to the site of infection, because the release of histotoxic granules into the surrounding tissue should be prevented. Once PMN migrate out of the circulatory system, they die spontaneously by apoptosis, are recognized by macrophages, and are cleared from the site of infection (Sladek and Rysanek, 2000). In the current study, a significant decrease in PMN viability, attributable to a significant increase in PMN apoptosis but not necrosis, was found after migration through a BME cell layer, with or without fibroblasts, compared with migration through models coated only with collagen. It should be noted that use of primary BME cells in our in vitro model gave similar results (Lamote et al., 2003). Our results suggest that diapedesis through BME cells, stimulated by ZAS, induces PMN apoptosis. The mechanism by which epithelial cells induce PMN apoptosis remains to be elucidated, although a role for the ß2-integrin subunits CD11b and CD18 has been suggested in humans. ß2-Integrins may play an important role in the stimulation of apoptosis, because CD18-deficient mice show depressed PMN apoptosis (Weinmann et al., 2003). Furthermore, the importance of CD11b and CD18 in enhancing tumor necrosis factor-
-stimulated apoptosis was shown by Walzog et al. (1997). This hypothesis was negated by Larsson et al. (2000), who reported that antiCD18 antibodies could stimulate apoptosis thus suggesting an inhibitory role for CD18.
In conclusion, in our study it has been shown that 17ß-estradiol suppresses the chemotactic ability as well as the viability of bovine blood PMN after migration through an in vitro model. The importance of epithelial cells but not fibroblasts as an inductor of apoptosis was also demonstrated. Although these important phenomena require further research with respect to their underlying mechanism of action, our results can contribute to a better understanding of the mechanism of immune depression around parturition.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication February 13, 2004. Accepted for publication May 21, 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. C. Loiselle, C. Ster, B. G. Talbot, X. Zhao, G. F. Wagner, Y. R. Boisclair, and P. Lacasse Impact of postpartum milking frequency on the immune system and the blood metabolite concentration of dairy cows J Dairy Sci, May 1, 2009; 92(5): 1900 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Piepers, S. De Vliegher, K. Demeyere, B. N. Lambrecht, A. de Kruif, E. Meyer, and G. Opsomer Technical note: Flow cytometric identification of bovine milk neutrophils and simultaneous quantification of their viability J Dairy Sci, February 1, 2009; 92(2): 626 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Burvenich, D. D. Bannerman, J. D. Lippolis, L. Peelman, B. J. Nonnecke, M. E. Kehrli Jr., and M. J. Paape Cumulative Physiological Events Influence the Inflammatory Response of the Bovine Udder to Escherichia coli Infections During the Transition Period J Dairy Sci, June 1, 2007; 90(13_suppl): E39 - E54. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |